Searched for
CGMP DEVIATIONS
Over 67,000 cases of deodorants sold at Walmart, Amazon recalled due to 'cGMP deviations'. What is it?- Over 67,000 cases of power stick deodorant recalled nationwide
- Power Stick Deodorant Recall: How to return and get refund? See product types, quantities, affected lot numbers, fda report, recall reason, retail stores
- Aurobindo Pharma recalls 4,608 bottles of pain relieving drug in USAurobindo Pharma is recalling over 4,600 bottles of a pain relief drug in the United States. The recall is due to manufacturing deviations....27 Jun, 2025, 03.41 PM IST
- USFDA pulls up Jagsonpal Pharmaceuticals for manufacturing lapses at API plantThe USFDA has issued a warning to Jagsonpal Pharmaceuticals following an inspection of its API plant in Rajasthan. The regulator highlighte...23 Feb, 2025, 03.17 PM IST
- Aurobindo Pharma, Glenmark recall products in USAurobindo, Glenmark, and Zydus are recalling pharmaceutical products in the US due to manufacturing issues. Aurobindo and Glenmark's recall...15 Dec, 2024, 02.00 PM IST
- Alembic, Aurobindo recall drugs in US marketAlembic Pharmaceuticals and Aurobindo Pharma are recalling products in the US due to manufacturing problems. Alembic is recalling 82,400 bo...21 Aug, 2023, 05.03 PM IST
- Documents potentially misleading in Aurobindo Pharma's Unit-VII: USFDAThe FDA conducted a cGMP (Current Good Manufacturing Practices) inspection at the Unit 7 manufacturing facility from September 19-27 this y...10 Oct, 2019, 05.22 PM IST
- USFDA warns Bengaluru-based Resonance Labs of manufacturing norms violationsAlthough the company committed to addressing issues identified with the water systems and cleaning validation, the overall response lacked ...15 Feb, 2017, 08.31 PM IST
- Ranbaxy integration: Sun Pharma may drop some non-strategic unitsSun Pharma may discontinue certain non-strategic businesses as part of its integration process with Ranbaxy Laboratories.01 Nov, 2015, 10.58 AM IST
- SPARC, Sun Pharma drop on USFDA revocation of approvalShares of SPARC closed 2.62 per cent lower at Rs 375.80 after hitting the day's low of Rs 368.50 on the exchange. Parent Sum Pharma ended 3...28 Sep, 2015, 03.57 PM IST
- Wockhardt recalls over 1.62 lakh cartons of drugs in USs per the information available on the US Food and Drug Administration's (USFDA) website, Mumbai-based Wockhardt is recalling the drugs for...16 Jul, 2015, 06.37 PM IST
- Two drugs manufactured by Wockhardt recalled in the USAccording to information on the US Food and Drug Administration (USFDA) website, 166 bottles of Captopril tablets of 50 mg strength are bei...05 Jun, 2015, 08.43 PM IST
- IPCA Lab reports 10.5 per cent loss, wipes out Rs 995 crore from its market valuationShares of IPCA Laboratories ended with sharp losses of 10.5 per cent, wiping-out Rs 995 crore from its market valuation today, amid reports...05 Nov, 2014, 07.17 PM IST
- IPCA Laboratories stock slumps 16 per centShares of IPCA Laboratories slumped nearly 16 per cent to hit its 52-week low in early trade amid reports of stock downgrade.05 Nov, 2014, 01.43 PM IST
- USFDA cites torn records, unclean toilets for banning Sun Pharma's Gujarat plantAnalysts had pointed out that the import alert by the US Food and Drug Administration on the facility was unlikely to cause any significant...03 Apr, 2014, 04.00 AM IST
- Ranbaxy drugs safe says Australian drug regulator"At present, there is no evidence that any of the products in the Australian market manufactured by Ranbaxy are of an unacceptable quality".03 Jul, 2013, 04.00 AM IST
- Jubilant arm recalls Pantoprazole Sodium drug from US marketThe US FDA cites the reason of recall as "cGMP deviations, oral products were not manufactured in accordance with good manufacturing practi...21 May, 2013, 04.10 AM IST
- Angel recommends 'Sell' on Ranbaxy LaboratoriesAngel Broking has recommended a sell rating for Ranbaxy Laboratories after a warning was issued against the company from US FDA for its Ohm...29 Dec, 2009, 11.21 AM IST
- US FDA issues warning letter to Ranbaxy's American subsidiaryThe US Food and Drug Administration issued a warning letter to Ranbaxy Labs' American subsidiary for violating current good manufacturing p...24 Dec, 2009, 05.34 PM IST
Load More
